Nanalysis Scientific (CVE:NSCI) Hits New 1-Year Low – Should You Sell?

Nanalysis Scientific Corp. (CVE:NSCIGet Free Report) shares reached a new 52-week low on Thursday . The stock traded as low as C$0.33 and last traded at C$0.37, with a volume of 102100 shares trading hands. The stock had previously closed at C$0.37.

Nanalysis Scientific Price Performance

The business has a 50-day moving average of C$0.39 and a 200 day moving average of C$0.41. The company has a market capitalization of C$41.27 million, a PE ratio of -3.04 and a beta of 0.72. The company has a debt-to-equity ratio of 71.72, a current ratio of 1.42 and a quick ratio of 1.11.

About Nanalysis Scientific

(Get Free Report)

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.

Featured Articles

Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.